港股異動丨閲文集團漲逾6% 攜手迪士尼打造全球首部星球大戰中文網絡文學
格隆匯10月17日丨閲文集團(0772.HK)漲逾6%,報30.55港元,近6個交易日累計漲幅逾18%,成交2750萬港元,總市值310億港元。昨日,閲文集團與迪士尼中國聯合宣佈,雙方在內容創作領域達成合作。星球大戰系列中文電子書首次亮相閲文集團旗下數字閲讀平台,這是迪士尼首次在國內開放星戰小説的電子版權。此外,閲文集團將參與打造全球首部由中國作家創作的星球大戰小説。閲文方面表示,藉助星球大戰IP的全球影響力可助力文化出海;通過這次合作,閲文可深度參與IP衍生產品的生產過程,加強目前國內網絡文學IP開發相對薄弱的環節。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.